Concepedia

Ansgar Resch

AR

9

Publications

397

Citations

9

H-Index

1998

Active since

Affiliations

Pfizer (Germany)(Current)

Pfizer (United States)

Charité - Universitätsmedizin Berlin

United BioSource Corporation (United Kingdom)

Ansgar Resch is an author at Pfizer (Germany) specializing in medicine, infection control, and drug resistance.

Top concepts

Publications per year

1998–2013

9

Publications

9

The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals

Ansgar Resch, Michael Wilke, Christian Fink · The European Journal of Health Economics · 2008 · 77 citations

, , +13

Antithrombogenic Coating of Stents Using a Biodegradable Drug Delivery Technology

Robert A. Herrmann, Gerhard Schmidmaier, Bruno Märkl et al. · Thrombosis and Haemostasis · 1999 · 66 citations

The Economic Costs of Overactive Bladder in Germany

Theodor Klotz, Bernd Brüggenjürgen, Martin Burkart et al. · European Urology · 2006 · 56 citations

, , +2

Burden of pulmonary arterial hypertension in Germany

Heinrike Wilkens, Friedrich Grimminger, Marius M. Hoeper et al. · Respiratory Medicine · 2010 · 51 citations

, , +6

Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany

E De Cock, Wolfgang A. Krueger, S. Sorensen et al. · Infection · 2009 · 44 citations · Full text

, , +11

Rows per page

1–5 of 9